GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (NAS:NEUP) » Definitions » YoY Rev. per Sh. Growth

NEUP (Neuphoria Therapeutics) YoY Rev. per Sh. Growth : 0.00% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Neuphoria Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Neuphoria Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 0.00%.

Neuphoria Therapeutics's Revenue per Share for the three months ended in Sep. 2024 was $0.00.

Neuphoria Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Neuphoria Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuphoria Therapeutics YoY Rev. per Sh. Growth Chart

Neuphoria Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -98.39 -100.00 - -100.00 -

Neuphoria Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neuphoria Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Neuphoria Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2024 )
=(Revenue per Share (A: Jun. 2024 )-Revenue per Share (A: Jun. 2023 ))/ | Revenue per Share (A: Jun. 2023 ) |
=(0-0)/ | 0 |
=N/A %

Neuphoria Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Jun. 2023 )) / | Revenue per Share (Q: Jun. 2023 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuphoria Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Neuphoria Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuphoria Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (NAS:NEUP) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
SMMT INCY MRNA BMRN INSM UTHR SRPT TECH RPRX PCVX VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
B1N0:Germany B1N0:Germany
Address
200 Greenhill Road, Eastwood, SA, AUS, 5063
Website
https://www.bionomics.com.au
Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.